Lilly reports new data indicating rise in opioid use for migraine treatment
Eli Lilly and Co. announced the upcoming presentation of data indicating rising rates of opioid use for the treatment of migraine based on results from the OVERCOME (Observational Survey of the Epidemiology, Treatment and Care of Migraine) study.